422 related articles for article (PubMed ID: 28101650)
1. Speech disorders in Parkinson's disease: early diagnostics and effects of medication and brain stimulation.
Brabenec L; Mekyska J; Galaz Z; Rektorova I
J Neural Transm (Vienna); 2017 Mar; 124(3):303-334. PubMed ID: 28101650
[TBL] [Abstract][Full Text] [Related]
2. [Speech and voice disorders in Parkinson's disease].
Martnez-Sánchez F
Rev Neurol; 2010 Nov; 51(9):542-50. PubMed ID: 20979034
[TBL] [Abstract][Full Text] [Related]
3. Early detection of speech and voice disorders in Parkinson's disease patients treated with subthalamic nucleus deep brain stimulation: a 1-year follow-up study.
Tsuboi T; Watanabe H; Tanaka Y; Ohdake R; Hattori M; Kawabata K; Hara K; Ito M; Fujimoto Y; Nakatsubo D; Maesawa S; Kajita Y; Katsuno M; Sobue G
J Neural Transm (Vienna); 2017 Dec; 124(12):1547-1556. PubMed ID: 29098450
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of speech impairment and upper limb motor dysfunction in Parkinson's disease.
Rusz J; Tykalová T; Krupička R; Zárubová K; Novotný M; Jech R; Szabó Z; Růžička E
J Neural Transm (Vienna); 2017 Apr; 124(4):463-470. PubMed ID: 27933492
[TBL] [Abstract][Full Text] [Related]
5. Speech disorders in Parkinson's disease: pathophysiology, medical management and surgical approaches.
Dashtipour K; Tafreshi A; Lee J; Crawley B
Neurodegener Dis Manag; 2018 Oct; 8(5):337-348. PubMed ID: 30223711
[TBL] [Abstract][Full Text] [Related]
6. Effects of dopaminergic replacement therapy on motor speech disorders in Parkinson's disease: longitudinal follow-up study on previously untreated patients.
Rusz J; Tykalová T; Klempíř J; Čmejla R; Růžička E
J Neural Transm (Vienna); 2016 Apr; 123(4):379-87. PubMed ID: 26843071
[TBL] [Abstract][Full Text] [Related]
7. Distinct phenotypes of speech and voice disorders in Parkinson's disease after subthalamic nucleus deep brain stimulation.
Tsuboi T; Watanabe H; Tanaka Y; Ohdake R; Yoneyama N; Hara K; Nakamura R; Watanabe H; Senda J; Atsuta N; Ito M; Hirayama M; Yamamoto M; Fujimoto Y; Kajita Y; Wakabayashi T; Sobue G
J Neurol Neurosurg Psychiatry; 2015 Aug; 86(8):856-64. PubMed ID: 25280914
[TBL] [Abstract][Full Text] [Related]
8. Quantitative acoustic measurements for characterization of speech and voice disorders in early untreated Parkinson's disease.
Rusz J; Cmejla R; Ruzickova H; Ruzicka E
J Acoust Soc Am; 2011 Jan; 129(1):350-67. PubMed ID: 21303016
[TBL] [Abstract][Full Text] [Related]
9. Correlation between acoustic speech characteristics and non-speech motor performance in Parkinson Disease.
Goberman AM
Med Sci Monit; 2005 Mar; 11(3):CR109-16. PubMed ID: 15735562
[TBL] [Abstract][Full Text] [Related]
10. Levodopa may modulate specific speech impairment in Parkinson's disease: an fMRI study.
Mračková M; Mareček R; Mekyska J; Košťálová M; Rektorová I
J Neural Transm (Vienna); 2024 Feb; 131(2):181-187. PubMed ID: 37943390
[TBL] [Abstract][Full Text] [Related]
11. Non-invasive stimulation of the auditory feedback area for improved articulation in Parkinson's disease.
Brabenec L; Klobusiakova P; Barton M; Mekyska J; Galaz Z; Zvoncak V; Kiska T; Mucha J; Smekal Z; Kostalova M; Rektorova I
Parkinsonism Relat Disord; 2019 Apr; 61():187-192. PubMed ID: 30337204
[TBL] [Abstract][Full Text] [Related]
12. Acoustic investigation of stress patterns in Parkinson's disease.
Tykalova T; Rusz J; Cmejla R; Ruzickova H; Ruzicka E
J Voice; 2014 Jan; 28(1):129.e1-129.e8. PubMed ID: 24094802
[TBL] [Abstract][Full Text] [Related]
13. Effect of Low versus High Frequency Subthalamic Deep Brain Stimulation on Speech Intelligibility and Verbal Fluency in Parkinson's Disease: A Double-Blind Study.
Grover T; Georgiev D; Kalliola R; Mahlknecht P; Zacharia A; Candelario J; Hyam J; Zrinzo L; Hariz M; Foltynie T; Limousin P; Jahanshahi M; Tripoliti E
J Parkinsons Dis; 2019; 9(1):141-151. PubMed ID: 30594934
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal Speech Change After Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease Patients: A 2-Year Prospective Study.
Tanaka Y; Tsuboi T; Watanabe H; Nakatsubo D; Maesawa S; Kato S; Kajita Y; Sato M; Oodake R; Hattori M; Yamamoto M; Wakabayashi T; Katsuno M; Sobue G
J Parkinsons Dis; 2020; 10(1):131-140. PubMed ID: 31884493
[TBL] [Abstract][Full Text] [Related]
15. Dysphonia and Dysarthria in People With Parkinson's Disease After Subthalamic Nucleus Deep Brain Stimulation: Effect of Frequency Modulation.
Morello ANDC; Beber BC; Fagundes VC; Cielo CA; Rieder CRM
J Voice; 2020 May; 34(3):477-484. PubMed ID: 30454944
[TBL] [Abstract][Full Text] [Related]
16. Articulation Features of Parkinson's Disease Patients with Subthalamic Nucleus Deep Brain Stimulation.
Tanaka Y; Tsuboi T; Watanabe H; Kajita Y; Nakatsubo D; Fujimoto Y; Ohdake R; Ito M; Atsuta N; Yamamoto M; Wakabayashi T; Katsuno M; Sobue G
J Parkinsons Dis; 2016 Oct; 6(4):811-819. PubMed ID: 27662325
[TBL] [Abstract][Full Text] [Related]
17. Parkinson's disease or atypical parkinsonism? The importance of acoustic voice analysis in differential diagnosis of speech disorders.
Kowalska-Taczanowska R; Friedman A; Koziorowski D
Brain Behav; 2020 Aug; 10(8):e01700. PubMed ID: 32525283
[TBL] [Abstract][Full Text] [Related]
18. Effects of bilateral subthalamic nucleus stimulation and medication on parkinsonian speech impairment.
D'Alatri L; Paludetti G; Contarino MF; Galla S; Marchese MR; Bentivoglio AR
J Voice; 2008 May; 22(3):365-72. PubMed ID: 17368837
[TBL] [Abstract][Full Text] [Related]
19. Speech, voice, and language outcomes following deep brain stimulation: A systematic review.
Tabari F; Berger JI; Flouty O; Copeland B; Greenlee JD; Johari K
PLoS One; 2024; 19(5):e0302739. PubMed ID: 38728329
[TBL] [Abstract][Full Text] [Related]
20. Deep brain stimulation and cognitive functions in Parkinson's disease: A three-year controlled study.
Zangaglia R; Pacchetti C; Pasotti C; Mancini F; Servello D; Sinforiani E; Cristina S; Sassi M; Nappi G
Mov Disord; 2009 Aug; 24(11):1621-8. PubMed ID: 19514093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
